Under-representation of the WHO African region in clinical trials of interventions against hepatitis B virus infection.

Saved in:
Bibliographic Details
Title: Under-representation of the WHO African region in clinical trials of interventions against hepatitis B virus infection.
Authors: Delphin M; The Francis Crick Institute, London, UK., Mohammed KS; The Francis Crick Institute, London, UK; Division of Biosciences, Faculty of Life Sciences, University College London, London, UK., Downs LO; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Department of Infectious Diseases and Microbiology, John Radcliffe Hospital, Oxford, UK; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Lumley SF; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Department of Infectious Diseases and Microbiology, John Radcliffe Hospital, Oxford, UK., Waddilove E; The Francis Crick Institute, London, UK., Okanda D; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Aliyan N; Kilifi County Hospital, Kilifi, Kenya., Van Schalkwyk M; Division of Infectious Diseases, Department of Medicine, Stellenbosch University-Tygerberg Academic Hospital, Cape Town, South Africa., Anderson M; The Francis Crick Institute, London, UK; Botswana Harvard AIDS Institute Partnership, Princess Marina Hospital, Gaborone, Botswana; Africa Health Research Institute, Durban, South Africa., Ocama P; College of Health Sciences, Makerere University, Kampala, Uganda., Maponga T; Division of Medical Virology, Stellenbosch University-National Health Laboratory Service Tygerberg Business Unit, Cape Town, South Africa., Torimiro J; Molecular Biology Laboratory, Chantal Biya International Reference Centre for AIDS Research, Yaounde, Cameroon., Iwuji C; Africa Health Research Institute, Durban, South Africa; Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton, UK., Ndung'u T; Division of Infection and Immunity, University College London, London, UK; Africa Health Research Institute, Durban, South Africa., Matthews PC; The Francis Crick Institute, London, UK; Division of Infection and Immunity, University College London, London, UK; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Department of Infectious Diseases, University College London Hospital, London, London, UK. Electronic address: philippa.matthews@crick.ac.uk., Taljaard J; Division of Infectious Diseases, Department of Medicine, Stellenbosch University-Tygerberg Academic Hospital, Cape Town, South Africa.
Source: The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2024 Apr; Vol. 9 (4), pp. 383-392. Date of Electronic Publication: 2024 Feb 15.
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101690683 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-1253 (Electronic) NLM ISO Abbreviation: Lancet Gastroenterol Hepatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2468-1253
DOI:10.1016/S2468-1253(23)00315-1